NANO-X IMAGING LTD Ordinary Shares (NNOX) is a publicly traded Healthcare sector company. As of May 21, 2026, NNOX trades at $1.78 with a market cap of $118.30M and a P/E ratio of 0.00. NNOX moved +4.62% today. Year to date, NNOX is -40.07%; over the trailing twelve months it is -67.03%. Its 52-week range spans $1.59 to $11.00. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces NNOX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nanox Secures NuvioDx Deal to Deploy FDA-Cleared ARC Systems in U.S. Clinics: Nanox Impact Inc. has secured a distribution deal with NuvioDx LLC to deploy FDA-cleared Nanox.ARC digital tomosynthesis systems across multiple U.S. clinical sites, expanding its channel partner network. The agreement enhances Nanox’s U.S. commercialization strategy by leveraging NuvioDx’s regional market access and operational capabilities.
| Metric | Value |
|---|---|
| Price | $1.78 |
| Market Cap | $118.30M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.00 |
| 52-Week Low | $1.59 |
| Volume | 7.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover NNOX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.